Short-Term Effects of Population-Based Screening for Prostate Cancer on Health-Related Quality of Life
Author(s) -
MarieLouise EssinkBot,
Harry J. de Koning,
H. G. T. Nijs,
Wim J. Kirkels,
P.J. van der Maas,
F.H. Schröder
Publication year - 1998
Publication title -
jnci journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/90.12.925
Subject(s) - medicine , prostate cancer , anxiety , quality of life (healthcare) , prostate cancer screening , population , rectal examination , gerontology , cancer , prostate specific antigen , psychiatry , environmental health , nursing
Population-based screening for prostate cancer is currently being evaluated in randomized clinical trials in the United States and in Europe. Side effects arising from the process of screening and from the earlier treatment of screen-detected prostate cancer may be important factors in the evaluation. To examine health-related quality of life (or health status) among men screened for prostate cancer, we conducted a longitudinal study of 626 attenders to the Rotterdam (The Netherlands) prostate cancer screening program and of 500 nonparticipants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom